Get started
Award

U01 DK048375

Funded outputs count: 90
Funder award ID: U01 DK048375
OpenAlex ID: G2491623767
Dysglycaemia and Autonomic Dysfunction: The Diabetes Prevention Program Outcomes Study
2026 · Justin B. Echouffo‐Tcheugui, Xun Liu, et al. · Diabetes Obesity and Metabolism
PDF
Implementing the National Alzheimer’s Coordinating Center Uniform Data Set (v3) within the Diabetes Prevention Program Outcomes Study
2026 · Lindsay K Doherty, Isabella Dechiario, et al. · medRxiv
PDF
Implementation of a standardized Video-based Asynchronous Neurological Examination (VANE) in a multi-center observational study of Alzheimer’s disease (AD) and AD related dementias
2026 · JM Noble, NK Nadkarni, et al. · medRxiv
Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study
2025 · Wei Perng, Shiyu Shu, et al. · Diabetologia · 4
PDF
Association of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study
2025 · José A. Luchsinger, Qing Pan, et al. · Obesity · 2
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study
2025 · Samuel Dagogo-Jack, Erin J. Kazemi, et al. · Diabetes Care
Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks
2025 · Emily Kobayashi, Nathaniel J. Linden-Santangeli, et al. · Diabetes Care · 9
Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study
2025 · William C. Knowler, Qing Pan, et al. · Diabetes Care
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes study
2025 · Ashley H Tjaden, Audrey A Goldbaum, et al. · American Journal of Clinical Nutrition · 1
Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS)
2025 · Ashley H. Tjaden, Barbara H. Braffett, et al. · Diabetes Care · 2
Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025 · William H. Herman, Adam Ciarleglio, et al. · Diabetes Care · 2
Correction to Lancet Diabetes Endocrinol 2025; published online April 28. https://doi.org/10.1016/S2213-8587(25)00022-1
2025 · The Lancet Diabetes & Endocrinology
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial
2025 · William C Knowler, William C Knowler, et al. · The Lancet Diabetes & Endocrinology · 38
The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
2025 · Jill P. Crandall, Dana Dabelea, et al. · Diabetes Care · 28
PDF
Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program
2025 · Brandy M. Heckman-Stoddard, Jill P. Crandall, et al. · Cancer Prevention Research · 12
A comment on “Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was”
2024 · William H. Herman, Shihchen Kuo, et al. · Diabetes Obesity and Metabolism · 1
Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With Prediabetes
2024 · Liana K. Billings, Kathleen A. Jablonski, et al. · Diabetes · 11
The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study
2024 · Allison L.B. Shapiro, Ashley H. Tjaden, et al. · Journal of Diabetes and its Complications · 2
Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure
2024 · Christine G. Lee, Adam Ciarleglio, et al. · Diabetes Care · 10
PDF
Prevalence and predictors of female sexual dysfunction among sexually active women in the diabetes prevention program outcomes study
2024 · Priyanka Gupta, Lindsay Doherty, et al. · Neurourology and Urodynamics · 3
PDF
Prevalence and predictors of erectile dysfunction among men in the diabetes prevention program outcomes study
2023 · Yooni A. Blair, Lindsay Doherty, et al. · Journal of Diabetes and its Complications · 5
Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study
2023 · Kishore M. Gadde, Xiaoyan Yin, et al. · Journal of the American Heart Association · 8
PDF
Effects of metformin and intensive lifestyle interventions on the incidence of kidney disease in adults in the DPP/DPPOS
2023 · Mark E. Molitch, Mark Tripputi, et al. · Journal of Diabetes and its Complications · 5
Association of Metformin With the Development of Age-Related Macular Degeneration
2022 · Amitha Domalpally, Samuel A. Whittier, et al. · JAMA Ophthalmology · 25
Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)
2022 · Josephine H. Li, James A. Perry, et al. · Diabetes · 20
PDF
Year
Topic